Wedbush Raises PT on Aclaris Therapeutics to $8 from $8, Maintains Outperform Rating

martes, 31 de marzo de 2026, 10:19 am ET1 min de lectura
ACRS--

Wedbush Raises PT on Aclaris Therapeutics to $8 from $8, Maintains Outperform Rating

Wedbush Raises PT on Aclaris Therapeutics to $8 from $8, Maintains Outperform Rating

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios